Business Context and Reporting Period
This Form 8-K filing by BiomX Inc. (PHGE) covers the reporting period ending June 10, 2026. The Company is incorporated in Delaware and its common stock is listed on the NYSE American. The filing addresses the Company's status regarding continued listing standards with the NYSE American LLC.
Key Financial Metrics
The filing references specific financial data from the Company's most recent fiscal year-end to explain the listing deficiency:
- Stockholders' Equity: A deficit of $(1,302,000) as of December 31, 2025.
- Profitability: The Company reported losses from continuing operations and/or net losses in its five most recent fiscal years.
- Other Metrics: The filing text does not provide clear values for revenue, cash flow, margins, debt, or liquidity beyond the equity deficit mentioned above.
Material Changes and Listing Status
On March 25, 2026, the Company received notice of non-compliance with NYSE American continued listing standards (Sections 1003(a)(i), (ii), and (iii)) due to insufficient stockholders' equity and historical losses. On June 10, 2026, NYSE Regulation accepted the Company's compliance plan submitted on April 24, 2026. Consequently:
- The Company has been granted a plan period through September 25, 2027, to regain compliance.
- Common stock will continue to trade on NYSE American during this period.
- A ".BC" (below compliance) indicator will be disseminated with the ticker symbol until compliance is regained.
Outlook, Risks, and Management Commentary
Management states it is committed to the actions set forth in the compliance plan and intends to use all reasonable efforts to regain compliance. However, the filing includes significant risk disclosures:
- Delisting Risk: If the Company fails to regain compliance by September 25, 2027, or fails to make progress consistent with the plan, NYSE Regulation may initiate delisting proceedings.
- Uncertainty: The Company provides no assurances that it will make satisfactory progress, regain compliance, or that future events will not adversely affect its ability to meet the standards.
- Guidance: No specific financial guidance or revenue outlook is provided in this filing.
Key Facts for Investor Verification
- Verify the specific initiatives and conditions outlined in the compliance plan submitted on April 24, 2026, to understand the path to regaining equity compliance.
- Monitor the ".BC" trading indicator on the NYSE American to track ongoing compliance status.
- Review the Company's upcoming quarterly and annual reports to assess progress in reducing the stockholders' deficit and achieving profitability.
- Confirm the deadline of September 25, 2027, as the final date to regain compliance before potential delisting proceedings.